Current practical applications of diagnostic immunohistochemistry in breast pathology

被引:117
作者
Lerwill, MF
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, James Homer Wright Pathol Labs, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1097/01.pas.0000126780.10029.f0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In recent years, immunohistochemistry has assumed an increasingly prominent role in diagnostic breast pathology. Immunohistochemistry is now frequently used in the evaluation of many epithelial proliferations of the breast. Common applications include the use of myoepithelial markers to evaluate for stromal invasion, E-cadherin to distinguish between ductal and lobular neoplasia, high molecular weight cytokeratins to differentiate usual ductal hyperplasia from ductal carcinoma in situ, immunohistochemical profiles to characterize site of origin of metastatic carcinomas, and cytokeratin stains to detect metastases in sentinel lymph nodes. Recent advances, practical considerations, and potential pitfalls in the use of immunohistochemistry in these five diagnostic categories are discussed herein.
引用
收藏
页码:1076 / 1091
页数:16
相关论文
共 122 条
[101]   Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer [J].
Silberstein, GB ;
VanHorn, K ;
Strickland, P ;
Roberts, CT ;
Daniel, CW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8132-8137
[102]  
Singletary S Eva, 2003, Semin Surg Oncol, V21, P53, DOI 10.1002/ssu.10021
[103]   Immunohistochemical staining for thyroid transcription factor-1: A helpful aid in discerning primary site of tumor origin in patients with brain metastases [J].
Srodon, M ;
Westra, WH .
HUMAN PATHOLOGY, 2002, 33 (06) :642-645
[104]   METASTATIC DISEASE TO BREAST - CLINICAL, PATHOLOGIC, AND RADIOGRAPHIC FEATURES [J].
TOOMBS, BD ;
KALISHER, L .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1977, 129 (04) :673-676
[105]  
Tot T, 1999, Ann Diagn Pathol, V3, P350, DOI 10.1016/S1092-9134(99)80013-6
[106]   The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract [J].
Tot, T .
APMIS, 2000, 108 (06) :467-472
[107]   Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma [J].
Tot, T .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (06) :758-763
[108]   Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging [J].
Turner, RR ;
Ollila, DW ;
Stern, S ;
Giuliano, AE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (03) :263-267
[109]   E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis [J].
Vos, CBJ ;
CletonJansen, AM ;
Berx, G ;
deLeeuw, WJF ;
terHaar, NT ;
vanRoy, F ;
Cornelisse, CJ ;
Peterse, JL ;
vandeVijver, MJ .
BRITISH JOURNAL OF CANCER, 1997, 76 (09) :1131-1133
[110]  
WANG NP, 1995, APPL IMMUNOHISTOCHEM, V3, P99